200 related articles for article (PubMed ID: 30510251)
61. The rat homologue of Wiskott-Aldrich syndrome protein (WASP)-interacting protein (WIP) associates with actin filaments, recruits N-WASP from the nucleus, and mediates mobilization of actin from stress fibers in favor of filopodia formation.
Vetterkind S; Miki H; Takenawa T; Klawitz I; Scheidtmann KH; Preuss U
J Biol Chem; 2002 Jan; 277(1):87-95. PubMed ID: 11687573
[TBL] [Abstract][Full Text] [Related]
62. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
[TBL] [Abstract][Full Text] [Related]
63. Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP.
Falet H; Marchetti MP; Hoffmeister KM; Massaad MJ; Geha RS; Hartwig JH
Blood; 2009 Nov; 114(21):4729-37. PubMed ID: 19692704
[TBL] [Abstract][Full Text] [Related]
64. Wiskott-Aldrich syndrome protein--dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes.
Matalon O; Reicher B; Barda-Saad M
Immunol Rev; 2013 Nov; 256(1):10-29. PubMed ID: 24117810
[TBL] [Abstract][Full Text] [Related]
65. Identification of Fyn as the binding partner for the WASP N-terminal domain in T cells.
Sato M; Sawahata R; Takenouchi T; Kitani H
Int Immunol; 2011 Aug; 23(8):493-502. PubMed ID: 21705469
[TBL] [Abstract][Full Text] [Related]
66. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
67. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
[TBL] [Abstract][Full Text] [Related]
68. The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis.
Haddad E; Zugaza JL; Louache F; Debili N; Crouin C; Schwarz K; Fischer A; Vainchenker W; Bertoglio J
Blood; 2001 Jan; 97(1):33-8. PubMed ID: 11133739
[TBL] [Abstract][Full Text] [Related]
69. Wiskott-Aldrich Syndrome causing mutation, Pro373Ser restricts conformational changes essential for WASP activity in T-cells.
Jain N; George B; Thanabalu T
Biochim Biophys Acta; 2014 Apr; 1842(4):623-34. PubMed ID: 24440360
[TBL] [Abstract][Full Text] [Related]
70. WASP suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of WIP.
Rajmohan R; Meng L; Yu S; Thanabalu T
Biochem Biophys Res Commun; 2006 Apr; 342(2):529-36. PubMed ID: 16488394
[TBL] [Abstract][Full Text] [Related]
71. STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma.
Spaccarotella E; Pellegrino E; Ferracin M; Ferreri C; Cuccuru G; Liu C; Iqbal J; Cantarella D; Taulli R; Provero P; Di Cunto F; Medico E; Negrini M; Chan WC; Inghirami G; Piva R
Haematologica; 2014 Jan; 99(1):116-24. PubMed ID: 23975180
[TBL] [Abstract][Full Text] [Related]
72. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.
Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z
BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608
[TBL] [Abstract][Full Text] [Related]
73. A novel anti-WIP monoclonal antibody detects an isoform of WIP that lacks the WASP binding domain.
Koduru S; Massaad M; Wilbur C; Kumar L; Geha R; Ramesh N
Biochem Biophys Res Commun; 2007 Feb; 353(4):875-81. PubMed ID: 17207458
[TBL] [Abstract][Full Text] [Related]
74. Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein.
Nguyen DD; Maillard MH; Cotta-de-Almeida V; Mizoguchi E; Klein C; Fuss I; Nagler C; Mizoguchi A; Bhan AK; Snapper SB
Gastroenterology; 2007 Oct; 133(4):1188-97. PubMed ID: 17764675
[TBL] [Abstract][Full Text] [Related]
75. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
76. A novel neural Wiskott-Aldrich syndrome protein (N-WASP) binding protein, WISH, induces Arp2/3 complex activation independent of Cdc42.
Fukuoka M; Suetsugu S; Miki H; Fukami K; Endo T; Takenawa T
J Cell Biol; 2001 Feb; 152(3):471-82. PubMed ID: 11157975
[TBL] [Abstract][Full Text] [Related]
77. EFC/F-BAR proteins and the N-WASP-WIP complex induce membrane curvature-dependent actin polymerization.
Takano K; Toyooka K; Suetsugu S
EMBO J; 2008 Nov; 27(21):2817-28. PubMed ID: 18923421
[TBL] [Abstract][Full Text] [Related]
78. The adapter protein CrkII regulates neuronal Wiskott-Aldrich syndrome protein, actin polymerization, and tension development during contractile stimulation of smooth muscle.
Tang DD; Zhang W; Gunst SJ
J Biol Chem; 2005 Jun; 280(24):23380-9. PubMed ID: 15834156
[TBL] [Abstract][Full Text] [Related]
79. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
80. WIP is necessary for matrix invasion by breast cancer cells.
García E; Machesky LM; Jones GE; Antón IM
Eur J Cell Biol; 2014 Oct; 93(10-12):413-23. PubMed ID: 25169059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
